Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics Corp (UTHR) · filed Feb 11, 2025

Accession no.
0001562180-25-001126
Filed
Feb 11, 2025
Trade date
Feb 10, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.48M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 10, 2025Common StockMOption exerciseAcquired+7,500$111.00+$832,5007,500Indirect
Feb 10, 2025Common StockSSaleDisposed−1,142$345.69F3−$394,777.986,358Indirect
Feb 10, 2025Common StockSSaleDisposed−200$346.53F4−$69,3066,158Indirect
Feb 10, 2025Common StockSSaleDisposed−3,697$347.98F5−$1,286,482.062,461Indirect
Feb 10, 2025Common StockSSaleDisposed−1,696$349.10F6−$592,073.6765Indirect
Feb 10, 2025Common StockSSaleDisposed−720$349.90F7−$251,92845Indirect
Feb 10, 2025Common StockSSaleDisposed−45$352.43−$15,859.350Indirect
Feb 10, 2025Common StockMOption exerciseAcquired+2,500$111.00+$277,5002,500Indirect
Feb 10, 2025Common StockSSaleDisposed−500$345.90F9−$172,9502,000Indirect
Feb 10, 2025Common StockSSaleDisposed−1,200$348.12F10−$417,744800Indirect
Feb 10, 2025Common StockSSaleDisposed−700$349.30F11−$244,510100Indirect
Feb 10, 2025Common StockSSaleDisposed−100$350.18−$35,0180Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 10, 2025Common StockMOption exerciseDisposed−2,500$0.00$09,500Indirect
Feb 10, 2025Common StockMOption exerciseDisposed−7,500$0.00$022,179Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $345.20 to $345.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $346.45 to $346.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $347.52 to $348.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $348.55 to $349.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $349.56 to $350.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $345.70 to $346.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $347.74 to $348.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F11

This transaction was executed in multiple trades at prices ranging from $348.93 to $349.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)